Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410110 · ClinicalTrials.gov registry record · Phase 2
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT01410110 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 48 participants.
The verdict
NCT01410110, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
The initial phase of substance abuse treatment is a vulnerable period for relapse. Cognitive impairments are common during this phase and may reduce the ability to benefit from other forms of substance abuse and rehabilitation services. The study compares a rehabilitation program that combines work therapy with computer-based cognitive training of attention, memory and executive functions to work therapy alone in a 3 months outpatient substance abuse program. It is hypothesized that cognitive training will increase days of sobriety during the active intervention and better substance abuse outcomes at 6 month follow-up.
Interventions
- BEHAVIORAL Cognitive Training + Work Therapy
- BEHAVIORAL Work Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01410110
The ClinicalTrials.gov registry entry for NCT01410110 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Training + Work Therapy is the first listed.
NCT01410110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01410110 about?
NCT01410110 is a clinical study titled "Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment". The initial phase of substance abuse treatment is a vulnerable period for relapse. Cognitive impairments are common during this phase and may reduce the ability to benefit from other forms of substance abuse and rehabilitation services. The study compares a rehabilitation program that combines work ...
What is the current status of trial NCT01410110?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2010-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01410110?
The interventions under investigation include: Cognitive Training + Work Therapy (BEHAVIORAL), Work Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01410110?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.